Alternative Data for Sophia Genetics SA
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 50 | Sign up | Sign up | Sign up |
| Webpage traffic | 28,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 250 | Sign up | Sign up | Sign up |
| X Mentions | 17 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Sophia Genetics SA
None
| Price | $4.49 |
| Target Price | Sign up |
| Volume | 83,559 |
| Market Cap | $295M |
| Year Range | $2.99 - $5.52 |
| Dividend Yield | 0% |
| Analyst Rating | 67% buy |
| Industry | Biotechnology |
In the news
 |
Why The Story Behind SOPHiA GENETICS (SOPH) Is Shifting After The Latest Target ResetFebruary 11 - Yahoo |
|
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health SystemsFebruary 9 - Yahoo |
SOPHiA GENETICS Adds Two U.S. Healthcare Systems To Its Network To Leverage AI-Native, Cloud-Based SOPHiA DDM To Analyze Complex Genomic Data At ScaleFebruary 9 - Benzinga |
|
|
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition PlanJanuary 11 - Yahoo |
 |
Sophia Genetics Q4 Earnings Summary & Key TakeawaysMarch 2 - Benzinga |
Sophia Genetics Sees FY2026 Sales $92.000M-$94.000M vs $88.000M EstMarch 2 - Benzinga |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 19M | 6.6M | 13M | -20M | -17M | -0.300 |
| Q2 '25 | 18M | 6.1M | 12M | -22M | -19M | -0.246 |
| Q1 '25 | 18M | 5.6M | 12M | -17M | -14M | -0.260 |
| Q4 '24 | 18M | 5.6M | 12M | -15M | -7.9M | -0.120 |
| Q3 '24 | 16M | 5.2M | 11M | -18M | -13M | -0.278 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about Sophia Genetics SA (SOPH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x mentions, news mentions & customer reviews.
FAQ - Sophia Genetics SA
The Market Cap of Sophia Genetics SA is $295M.
Currently, the price of one share of Sophia Genetics SA stock is $4.49.
The SOPH stock price chart above provides a comprehensive visual representation of Sophia Genetics SA's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Sophia Genetics SA shares. Our platform offers an up-to-date SOPH stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Sophia Genetics SA (SOPH) does not offer dividends to its shareholders. Investors interested in Sophia Genetics SA should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Sophia Genetics SA are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
